Ionis Pharmaceuticals
IONS
#1567
Rank
โ‚ฌ11.36 B
Marketcap
70,15ย โ‚ฌ
Share price
-0.16%
Change (1 day)
94.49%
Change (1 year)

Revenue for Ionis Pharmaceuticals (IONS)

Revenue in 2025 (TTM): โ‚ฌ0.85 Billion

According to Ionis Pharmaceuticals 's latest financial reports the company's current revenue (TTM ) is โ‚ฌ0.83 Billion. In 2024 the company made a revenue of โ‚ฌ0.67 Billion a decrease over the revenue in the year 2023 that were of โ‚ฌ0.71 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Ionis Pharmaceuticals from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚ฌ0.85 B26.39%
2024 โ‚ฌ0.67 B-4.9%
2023 โ‚ฌ0.71 B30.12%
2022 โ‚ฌ0.54 B-23.48%
2021 โ‚ฌ0.71 B20.7%
2020 โ‚ฌ0.59 B-40.83%
2019 โ‚ฌ1.00 B91.17%
2018 โ‚ฌ0.52 B21.26%
2017 โ‚ฌ0.43 B31.18%
2016 โ‚ฌ0.32 B27%
2015 โ‚ฌ0.25 B47.35%
2014 โ‚ฌ0.17 B65.11%
2013 โ‚ฌ0.10 B38.24%
2012 โ‚ฌ77.14 M1.11%
2011 โ‚ฌ76.29 M-6.44%
2010 โ‚ฌ81.55 M-3.92%
2009 โ‚ฌ84.87 M20.83%
2008 โ‚ฌ70.24 M47.32%
2007 โ‚ฌ47.68 M156.48%
2006 โ‚ฌ18.59 M-45.12%
2005 โ‚ฌ33.87 M7.82%
2004 โ‚ฌ31.42 M-20.86%
2003 โ‚ฌ39.7 M-48.23%
2002 โ‚ฌ76.7 M27.15%
2001 โ‚ฌ60.32 M52.53%
2000 โ‚ฌ39.54 M17.39%
1999 โ‚ฌ33.68 M2.24%
1998 โ‚ฌ32.94 M20.68%
1997 โ‚ฌ27.3 M43.36%
1996 โ‚ฌ19.04 M

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
โ‚ฌ0.11 B-85.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas